| Data show that gastric cancer markers MUC2, and oncogenes c-myc, cyclin E1 were expressed in the gastric carcinoma cell line 3I (MGCC3I). | gastric, |
| Establishment of an orthotopic transplantable gastric cancer animal model for studying the immunological effects of new cancer therapeutic modules. | gastric, |
| Structural features of the amplified N-myc oncogene detected by micrococcal nuclease digestion of neuroblastoma cell nuclei. | neuroblastoma, |
| Overexpression of C-MYC oncogene in prostate cancer predicts biochemical recurrence. | prostate, |
| B-cell activating factor and v-Myc myelocytomatosis viral oncogene homolog (c-Myc) influence progression of chronic lymphocytic leukemia. | leukemia, |
| C-myc oncogene product p62 in ovarian mucinous neoplasms. | neoplasm,ovarian, |
| [Immunohistological study on ras and myc oncogene products in pancreatic cancer]. | pancreatic, |
| Cathepsin D assay in primary breast cancer and lymph nodes: relationship with c-myc, c-erb-B-2 and int-2 oncogene amplification and node invasiveness. | breast, |
| Circulating antibodies against c-myc oncogene product in sera of colorectal cancer patients. | colorectal, |
| overexpression of the MYC oncogene increases nucleolar number and size and a nucleolar program of gene expression in prostate epithelial cells | prostate, |
| [Role of microRNA-223 and its target gene oncogene c-myc in hepatocellular carcinoma pathogenesis]. | liver, |
| Posttranscriptional deregulation of MYC via PTEN constitutes a major alternative pathway of MYC activation in T-cell acute lymphoblastic leukemia. | leukemia, |
| Gene expression of neuropeptide Y and neuropeptide-Y1 receptor in relation to proto-oncogene tyrosine kinase A, nerve-growth-factor low-affinity-receptor and the transcription factor N-myc in human neuroblastomas. | neuroblastoma, |
| Analysis of the activation of the myc family oncogene and of its stability over time in xenografted human lung carcinomas. | lung, |
| Effects of linoleic acid and eicosanoid synthesis inhibitors on the growth and c-myc oncogene expression of human breast cancer cells. | breast, |
| Co-overexpression of bcl-2 and c-myc in uterine cervix carcinomas and premalignant lesions. | uterine, |
| Rflp analysis of the L-myc oncogene in head and neck-cancer - relationship study with susceptibility and disease progression. | HNSC, |
| Dissection of the oncogenic MYCN transcriptional network reveals a large set of clinically relevant cell cycle genes as drivers of neuroblastoma tumorigenesis. | neuroblastoma, |
| Human breast-carcinoma cells show correlation in expression of C-myc oncogene and the C-myc binding-protein (mbp-1). | breast, |
| Alterations in growth properties of human papilloma virus type 16 immortalised human cervical keratinocyte cell line correlate with amplification and overexpression of c-myc oncogene. | cervical, |